AIM ImmunoTech Announces First Dose Level is Generally
Next safety cohort to begin escalated dosing soon...
Source: globenewswire.com
Nyse Aim News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse Aim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Aim Today - Breaking & Trending Today
AIM ImmunoTech (AIM) Scheduled to Post Earnings on Tuesday
AIM ImmunoTech (NYSE:AIM – Get Free Report) will issue its quarterly earnings data on Tuesday, April 2nd. AIM ImmunoTech Trading Up 6.3 % Shares of NYSE AIM opened at $0.47 on Monday. AIM ImmunoTech has a one year low of $0.32 and a one year high of $0.75. The firm has a market capitalization of […]
Source: etfdailynews.com
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma
Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET...
Source: globenewswire.com
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023
OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will...
Source: globenewswire.com
Reviewing Poseida Therapeutics (NASDAQ:PSTX) and AIM ImmunoTech (NYSE:AIM)
AIM ImmunoTech (NYSE:AIM – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Insider and Institutional Ownership 12.8% of AIM […]
Source: wkrb13.com